Skip to main content
. 2022 May 26;9:854107. doi: 10.3389/fcvm.2022.854107

FIGURE 2.

FIGURE 2

Kaplan-Meier survival analysis. (A) Major adverse cardiovascular events (MACE) in diabetic patients; (B) secondary end points in diabetic patients; (C) MACE in non-diabetic patients; and (D) secondary end points in non-diabetic patients.